Educational comparison - not medical advice. This page compares two compounds for informational purposes. Neither is recommended as treatment. Any protocol decision is a conversation with your licensed healthcare provider.
Tesamorelin is a GHRH analog - FDA-approved (Egrifta) for HIV-lipodystrophy, strong IGF-1 elevation (40-80%) at 1-2mg nightly. Ipamorelin is a GHRP (ghrelin receptor agonist) - milder IGF-1 response alone, but synergistic when stacked with CJC-1295 no-DAC. Tesamorelin preferred when max IGF-1 response desired; ipamorelin + CJC-1295 preferred for cleaner pulsatile profile and lower cost.
Informational only - neither compound is presented as a treatment for any condition. These are contexts in which users research these compounds and discuss them with their licensed provider.
Informational comparison only - not medical advice. Research-stage compounds discussed are not FDA-approved unless specifically noted. Any protocol decision should be made with a licensed healthcare provider.